NOD 小鼠糖尿病决定早期窗口,依赖补体受体 CRIG,通过无创成像鉴定。
Early window of diabetes determinism in NOD mice, dependent on the complement receptor CRIg, identified by noninvasive imaging.
机构信息
Division of Immunology, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.
出版信息
Nat Immunol. 2012 Feb 26;13(4):361-8. doi: 10.1038/ni.2233.
All juvenile mice of the nonobese diabetic (NOD) strain develop insulitis, but there is considerable variation in their progression to diabetes. Here we used a strategy based on magnetic resonance imaging (MRI) of magnetic nanoparticles to noninvasively visualize local effects of pancreatic-islet inflammation to predict the onset of diabetes in NOD mice. MRI signals acquired during a narrow early time window allowed us to sort mice into groups that would progress to clinical disease or not and to estimate the time to diabetes development. We exploited this approach to identify previously unknown molecular and cellular elements correlated with disease protection, including the complement receptor of the immunoglobulin superfamily (CRIg), which marked a subset of macrophages associated with diabetes resistance. Administration of a fusion of CRIg and the Fc portion of immunoglobulin resulted in lower MRI signals and diabetes incidence. In addition to identifying regulators of disease progression, we show here that diabetes is set at an early age in NOD mice.
所有非肥胖型糖尿病(NOD)品系的幼年小鼠均会发生胰岛炎,但它们向糖尿病发展的进程存在较大差异。在这里,我们使用了一种基于磁共振成像(MRI)的磁性纳米粒子的策略,来非侵入性地可视化胰岛炎症的局部影响,从而预测 NOD 小鼠糖尿病的发病。在一个狭窄的早期时间窗口期间获得的 MRI 信号,使我们能够将小鼠分为进展为临床疾病或不进展为临床疾病的组,并估计糖尿病发展的时间。我们利用这种方法来识别与疾病保护相关的以前未知的分子和细胞成分,包括免疫球蛋白超家族的补体受体(CRIg),它标记了与糖尿病抵抗相关的巨噬细胞亚群。CRIg 与免疫球蛋白的 Fc 部分融合物的给药导致 MRI 信号降低和糖尿病发病率降低。除了鉴定疾病进展的调节剂外,我们在这里还表明,NOD 小鼠的糖尿病在早期就已确定。